Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$592K Buy
21,100
+8,550
+68% +$228K 0.16% 98
2025
Q4
$312K Buy
12,550
+1,243
+11% +$31.3K 0.1% 126
2025
Q3
$288K Buy
11,307
+350
+3% +$8.64K 0.1% 122
2025
Q2
$266K Buy
10,957
+1,229
+13% +$28.7K 0.1% 112
2025
Q1
$247K Buy
9,728
+1,200
+14% +$31.4K 0.11% 118
2024
Q4
$226K Buy
8,528
+1,500
+21% +$40.7K 0.1% 115
2024
Q3
$203K Sell
7,028
-1,250
-15% -$36.5K 0.1% 125
2024
Q2
$232K Buy
+8,278
New +$228K 0.12% 114
2023
Q1
Sell
-4,480
Closed -$287K 127
2022
Q4
$287K Sell
4,480
-520
-10% -$24.9K 0.18% 99
2022
Q3
$219K Sell
5,000
-246
-5% -$12K 0.14% 105
2022
Q2
$275K Buy
5,246
+4
+0.1% +$204 0.16% 100
2022
Q1
$271K Sell
5,242
-745
-12% -$38.7K 0.13% 106
2021
Q4
$354K Buy
5,987
+3
+0.1% +$149 0.18% 88
2021
Q3
$257K Sell
5,984
-496
-8% -$22K 0.15% 110
2021
Q2
$257K Hold
6,480
0.16% 100
2021
Q1
$238K Sell
6,480
-2,486
-28% -$88.3K 0.14% 106
2020
Q4
$331K Buy
+8,966
New +$329K 0.25% 77

Other funds holding PFE

COWA LLC's PFE Position: Q1 2026 in Review

COWA LLC increased its Pfizer (PFE) stake by 68% in Q1 2026, buying an estimated $228K and bringing the position to 21,100 shares worth $592K. The position accounts for 0.16% of the portfolio, ranked #98.

COWA LLC first reported a position in PFE in Q4 2020 and has held it in 17 quarters since. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • COWA LLC held 21,100 shares of Pfizer worth $592K as of Q1 2026.
  • COWA LLC bought 8,550 Pfizer shares in Q1 2026, an estimated $228K.
  • Pfizer made up 0.16% of COWA LLC's portfolio in Q1 2026, its #98 holding.
  • COWA LLC first reported a position in Pfizer in Q4 2020 and has held it in 17 quarters since.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on COWA LLC's 13F filing for Q1 2026, filed 14 May 2026.